🇺🇸 FDA
Pipeline program

RANOLAZINE, FLECARDIA Διάλυμα για ένεση/έχχυση

Phase 3 small_molecule active

Quick answer

RANOLAZINE, FLECARDIA Διάλυμα για ένεση/έχχυση for Restoration of sinus rhythm in patients with recent AF onset is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
Restoration of sinus rhythm in patients with recent AF onset
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials